← SynDRA
GW-311616
SynDRA canonical compound SYN1965263 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ELANE |
|---|
| Mechanism of action | elastase inhibitor | leukocyte elastase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- elastase inhibitor
- leukocyte elastase inhibitor
Cross-references
Synonyms
- XVDWNSFFSMWXJJ-BDRHRQAXSA-N
- UNII-HN0T99OO4V component XVDWNSFFSMWXJJ-BDRHRQAXSA-N
- N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl) ethyl]amino]methyl]phenyl]-2E-2-propenamide D-(-)-lactate salt
- n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide d-(-)-lactate salt
Look up GW-311616 in the interactive SynDRA portal →